BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17980666)

  • 1. Learning from failed trials in ALS.
    Swash M
    Lancet Neurol; 2007 Dec; 6(12):1034-5. PubMed ID: 17980666
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: What is next in ALS clinical trials?
    Hoke A
    Neurology; 2008 Apr; 70(16):1366; author reply 1366-7. PubMed ID: 18413595
    [No Abstract]   [Full Text] [Related]  

  • 3. We have a problem: why have ALS trials been negative?
    Swash M
    Amyotroph Lateral Scler; 2007 Oct; 8(5):259. PubMed ID: 17917847
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors.
    J Neurol Sci; 1995 May; 129 Suppl():1-10. PubMed ID: 7595596
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient-led research in amyotrophic lateral sclerosis: Quo vadis?
    Stefanou MI; Amygdalos I
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):418-22. PubMed ID: 25800785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials.
    de Carvalho M; Chio A; Dengler R; Hecht M; Weber M; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):17-28. PubMed ID: 16036422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements.
    de Carvalho M; Costa J; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):202-12. PubMed ID: 16319023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in ALS: measurement and natural history.
    Munsat TL; Hollander D; Andres P; Finison L
    Adv Neurol; 1991; 56():515-9. PubMed ID: 1853780
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: What is next in ALS clinical trials?
    Harel NY
    Neurology; 2008 Apr; 70(16):1365-6; author reply 1365-6. PubMed ID: 18413594
    [No Abstract]   [Full Text] [Related]  

  • 13. Zeroing in on Amyotrophic lateral sclerosis. A look at a new era of ALS research.
    Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):4-5. PubMed ID: 26685335
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis.
    Gladman M; Cudkowicz M; Zinman L
    Curr Opin Neurol; 2012 Dec; 25(6):735-42. PubMed ID: 23160423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summing up: An action plan for ALS research.
    Rowland LP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():141-3. PubMed ID: 15512899
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotective agents for clinical trials in ALS: systematic assessment.
    Burke WJ
    Neurology; 2007 Feb; 68(9):709; author reply 710. PubMed ID: 17325287
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventilation in ALS.
    de Carvalho M; Pinto A
    Amyotroph Lateral Scler; 2006 Mar; 7(1):3-4. PubMed ID: 16546752
    [No Abstract]   [Full Text] [Related]  

  • 18. ALS trial design: expectation and reality.
    Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():52-4. PubMed ID: 15512873
    [No Abstract]   [Full Text] [Related]  

  • 19. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic trials in ALS.
    Bradley W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):6-7. PubMed ID: 12745610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.